Biotechnology

Zoology · free study notes

Biotechnology – Advanced Study Notes

(Medical Lab Technology – Biology – MIT‑level)


1. Introduction

Term Definition Core Idea
Biotechnology The application of biological systems or organisms to develop or modify products and processes for specific uses. Leverages molecular and cellular mechanisms to engineer desired traits.
Genetic Engineering Direct manipulation of an organism's genome using recombinant DNA techniques. Enables precise, heritable changes.
Synthetic Biology Design‑build‑test cycles for constructing novel biological parts, devices, and systems. Blends engineering principles with biology.
Bioprocessing Production of valuable biomolecules (proteins, nucleic acids, metabolites) at scale. Requires process optimization (upstream/downstream).

2. First Principles

2.1 Molecular Basis of Life

  • DNA: Double‑helix, Watson–Crick base pairing, replication fidelity governed by DNA polymerases and proofreading.
  • RNA: Single‑stranded, central to gene expression (mRNA, tRNA, rRNA).
  • Proteins: Polypeptide chains folded by the Anfinsen hypothesis; structure dictates function.

2.2 Gene Expression Regulation

  • Transcription: RNA polymerase holoenzyme; promoter recognition (σ factors in bacteria, TATA box in eukaryotes).
  • Post‑transcriptional: RNA splicing, editing, stability.
  • Translation: Ribosome, codon‑anticodon pairing, elongation factors.
  • Post‑translational: PTMs (phosphorylation, glycosylation), protein‑protein interactions.

2.3 DNA Manipulation Tools

  • Restriction Enzymes: Sequence‑specific endonucleases; produce sticky or blunt ends.
  • Ligases: DNA ligase (ATP‑dependent) covalently joins nicks.
  • Polymerases: PCR (Taq), high‑fidelity (Pfu), isothermal amplification (LAMP, RPA).
  • CRISPR‑Cas Systems: RNA‑guided nucleases (Cas9, Cas12, Cas13); programmable DNA/RNA editing.

3. Core Techniques in Biotechnology

Technique Principle Applications Key Considerations
Cloning Insertion of DNA fragment into plasmid/virus vector Gene expression, recombinant protein production Vector copy number, promoter strength, host strain
Transformation Uptake of foreign DNA by cells Bacterial, yeast, mammalian transfection Electroporation vs chemical; selection markers
Transfection Delivery of plasmid DNA into eukaryotic cells Gene therapy, vaccine development Efficiency, cytotoxicity, integration vs episomal
Protein Expression Production of recombinant protein in host Therapeutic proteins, enzymes Codon optimization, post‑translational modifications
Purification Isolation of target protein Biopharmaceutical production Affinity tags, chromatography (IMAC, ion exchange)

4. Advanced Topics

4.1 Gene Editing – CRISPR/Cas Systems

  • Components: Cas nuclease, guide RNA (gRNA), PAM sequence.
  • Mechanism: Double‑strand break → Non‑homologous end joining (NHEJ) or Homology‑Directed Repair (HDR).
  • Ethical Edge Cases: Off‑target effects, germline editing, mosaicism.

4.2 Synthetic Biology – Design Principles

  • Modularity: Parts (promoters, RBS, coding sequences) treated as Lego bricks.
  • Standardization: Biobricks, Registry of Standard Biological Parts.
  • Modeling: Systems biology (ODE, stochastic simulations) to predict behavior.

4.3 Metabolic Engineering

  • Flux Balance Analysis (FBA): Constraint‑based modeling to predict metabolic fluxes.
  • Rewiring Pathways: Knockout, overexpress, introduce heterologous enzymes.
  • Industrial Production: Biofuels, antibiotics, specialty chemicals.

4.4 Bioprocess Engineering

  • Upstream: Cell culture, media optimization, bioreactor design.
  • Downstream: Harvesting, clarification, chromatography, formulation.
  • Scale‑up Challenges: Shear stress, oxygen transfer, heat removal.

5. Edge Cases & Common Pitfalls

Scenario Problem Mitigation
Promoter leakage Unintended expression in absence of inducer Use tight regulation systems (lacI, tetR).
Plasmid instability Loss of copy number over generations Incorporate partitioning systems (par loci).
Protein aggregation Insoluble inclusion bodies Lower temperature, co‑expression of chaperones.
Off‑target CRISPR editing Unintended mutations Use high‑fidelity Cas variants, truncated gRNAs.
Batch variability Inconsistent yields Implement process analytical technology (PAT).

6. Mathematical Foundations

6.1 PCR Efficiency

Let ( N_t ) be the number of DNA molecules after ( t ) cycles.
( N_t = N_0 (1+E)^t )
where ( E ) is the efficiency (0–1).
Edge case: ( E < 0.9 ) leads to exponential plateau; requires optimization of primer design and polymerase.

6.2 Gene Expression Modelling

For a single gene:
( \frac{d[mRNA]}{dt} = k_{\text{transcription}} - \gamma_{\text{mRNA}}[mRNA] )
( \frac{d[Protein]}{dt} = k_{\text{translation}}[mRNA] - \gamma_{\text{protein}}[Protein] )
Steady‑state solutions provide insight into protein abundance.


7. Challenging Problem

Scenario
You are tasked with engineering E. coli to produce a therapeutic glycoprotein that requires complex N‑linked glycosylation. Native E. coli lacks the machinery.

Questions

  1. Design Strategy

    • Outline a step‑by‑step plan to introduce eukaryotic glycosylation pathways into E. coli.
    • Specify the essential genes, promoters, and host strain modifications.
  2. Quantitative Analysis

    • Given the following parameters:
      • Glycosyltransferase expression level (= 5 \times 10^7 ) molecules/cell.
      • Substrate availability: UDP‑GlcNAc (= 1

Your note

Page 1

Doubt hai is topic me?

Free AI teacher se poocho — 24/7, step by step.